IRIS
FAGONE, PAOLO FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.912
EU - Europa 2.069
AS - Asia 1.487
SA - Sud America 402
AF - Africa 375
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 8.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.781
IT - Italia 855
SG - Singapore 804
CN - Cina 446
IE - Irlanda 435
BR - Brasile 378
UA - Ucraina 277
CI - Costa d'Avorio 175
SN - Senegal 155
DE - Germania 146
RU - Federazione Russa 128
CA - Canada 109
SE - Svezia 50
VN - Vietnam 49
GB - Regno Unito 43
KR - Corea 35
IN - India 34
FI - Finlandia 21
FR - Francia 20
IR - Iran 18
BE - Belgio 17
BD - Bangladesh 15
IQ - Iraq 15
CH - Svizzera 13
MX - Messico 13
AR - Argentina 12
UZ - Uzbekistan 12
ZA - Sudafrica 11
NG - Nigeria 10
NL - Olanda 10
PL - Polonia 9
JP - Giappone 8
AT - Austria 7
PK - Pakistan 7
TR - Turchia 7
BG - Bulgaria 6
GE - Georgia 6
GR - Grecia 6
HK - Hong Kong 6
AE - Emirati Arabi Uniti 5
EU - Europa 5
KE - Kenya 5
MA - Marocco 5
VE - Venezuela 5
AU - Australia 4
ES - Italia 4
LB - Libano 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
EC - Ecuador 3
EG - Egitto 3
ET - Etiopia 3
JO - Giordania 3
MK - Macedonia 3
RO - Romania 3
SA - Arabia Saudita 3
TN - Tunisia 3
AO - Angola 2
DZ - Algeria 2
HU - Ungheria 2
IL - Israele 2
LT - Lituania 2
SY - Repubblica araba siriana 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.255
Salva come PNG Salva come JPEG
Città #
Santa Clara 789
Singapore 491
Chandler 464
Dublin 434
Jacksonville 307
Chicago 279
Boardman 204
Houston 199
Catania 180
Abidjan 175
Dakar 155
Ashburn 129
Cambridge 118
Lawrence 118
Andover 113
Nanjing 88
Civitanova Marche 84
Hefei 75
Toronto 75
Des Moines 65
San Mateo 51
Wilmington 48
Grafing 45
Palermo 37
Dong Ket 36
Saint Petersburg 34
Seoul 34
Rome 33
The Dalles 32
Columbus 31
Beijing 30
Nanchang 29
Los Angeles 28
Ottawa 27
Jiaxing 26
Munich 26
São Paulo 25
Hebei 23
Nizza di Sicilia 23
Council Bluffs 22
Vercelli 21
Washington 19
Bremen 18
Messina 18
Rio de Janeiro 18
Sant'Antonio Abate 18
Tianjin 18
Brussels 17
Acireale 16
Changsha 15
Moscow 15
Augusta 14
Lappeenranta 13
Milan 13
New York 13
Shenyang 13
Ardabil 12
Leawood 12
San Francisco 11
Abuja 10
Boston 10
Dearborn 10
Brooklyn 9
Licata 9
Padova 9
Chiaramonte Gulfi 8
London 8
Mascalucia 8
Ragusa 8
Baghdad 7
Dhaka 7
Hangzhou 7
Johannesburg 7
Monmouth Junction 7
Motta Sant'Anastasia 7
Norwalk 7
Pozzallo 7
Vicenza 7
Assago 6
Belo Horizonte 6
Campinas 6
Falls Church 6
Hanoi 6
Jinan 6
Kochi 6
Paris 6
Shanghai 6
Tappahannock 6
Tbilisi 6
Tokyo 6
Vienna 6
Amsterdam 5
Curitiba 5
Den Haag 5
Guangzhou 5
Hong Kong 5
Mumbai 5
Phoenix 5
Porto Alegre 5
Pune 5
Totale 5.751
Salva come PNG Salva come JPEG
Nome #
The role of macrophages in neuroinflammatory and neurodegenerative pathways of alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets 207
Differential modulation and prognostic values of immune-escape genes in uveal melanoma 152
KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms 131
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets 109
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 107
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 96
Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? 92
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma 91
Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. 89
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. 87
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis 85
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 82
Exploratory analysis of iPSCS-derived neuronal cells as predictors of diagnosis and treatment of Alzheimer disease 80
Advances in targeting signal transduction pathways. 79
Emerging therapeutic targets for the treatment of hepatic fibrosis 78
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 78
Characterization of the pathophysiological role of CD47 in uveal melanoma 78
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-Releasing Molecule CORM-A1, in a murine model of Autoimmune Hepatitis 77
Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis. 76
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 76
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 76
Identification of novel targets for the diagnosis and treatment of liver fibrosis. 76
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis 75
CD4+T-cell gene expression of healthy donors, HIV-1 and elite controllers: Immunological chaos 74
Impaired expression of tetraspanin 32 (TSPAN32) in memory T cells of patients with multiple sclerosis 74
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy 73
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets 73
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs 72
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis 72
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. 72
Vitamin D3 inhibits TNFα-induced latent HIV reactivation in J-LAT cells. 71
Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis 71
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences 71
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF 71
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 70
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 70
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells 69
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 68
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 68
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer 67
Modulation of heat shock proteins during macrophage differentiation. 67
Hypomethylating agent 5-aza-2 ′-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models 66
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway 66
Cathepsin A levels in CD4+ T cells from HIV-positive patients 66
mTOR as a multifunctional therapeutic target in HIV infection 64
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 64
Effects of GIT-27NO, a NO-donating compound, on hepatic ischemia/reperfusion injury 64
Therapeutic potential of nitric oxide-modified drugs in colon cancer cells 64
No-Modified Saquinavir is Equally Efficient Against Doxorubicin Sensitive and Resistant Non-Small Cell Lung Carcinoma Cells/MODIFIKOVANA KOVANA FORMA SAKVINAVIRA EFIKASNO SU PRIMI RA RAST ĆELIJA NESITNOĆELIJSKOG KARCINOMA PLUĆA RAZLIČITE OSETUIVOSTI NA DOKSORUBICIN 64
The dichotomic role of macrophage migration inhibitory factor in neurodegeneration 64
The cytokine network in the pathogenesis of major depressive disorder. Close to translation? 64
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus 64
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2 63
Sensitization of cancer stem cells based on inhibiting key signal transduction pathways 63
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 63
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis 63
Immunoexpression and localization of heme-oxygenase-1 and MIF in lung exposed to asbestos-like fibers: an in vivo study 63
The effect of omega-3 fatty acids on capsular tissue around the breast implants 63
Overexpression of macrophage migration inhibitory factor and its homologue d-dopachrome tautomerase as negative prognostic factor in neuroblastoma 63
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 62
Expression of DNA methylation genes in secondary progressive multiple sclerosis 62
Comprehensive analysis of rna-seq gene expression profiling of brain transcriptomes reveals novel genes, regulators, and pathways in autism spectrum disorder 62
The immunobiology of apotransferrin in type 1 diabetes 60
Meta-analysis of transcriptomic data of dorsolateral prefrontal cortex and of peripheral blood mononuclear cells identifies altered pathways in Schizophrenia 60
Effects of treatment with the hypomethylating agent 5-aza-2’-deoxycytidine in murine type ii collagen-induced arthritis 60
Identification of Common Pathogenetic Processes between Schizophrenia and Diabetes Mellitus by Systems Biology Analysis 60
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor 59
Naturally occurring compounds in differentiation based therapy of cancer. 59
Effects of Synthetic Anti-Inflammatory Sterol in CB3V-Induced Myocarditis: A Morphological Study on Heart Muscle Tissue 59
Role of NGAL (Lcn2) in prostate cancer invasion 58
Immune modifying capacity of new melanoma therapeutics with the potency to increase efficacy of Adoptive T-cell Therapy – potential synergism of combinations 58
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 58
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients 58
17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease 58
Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders 58
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1 57
Modulation of tetraspanin 32 (TSPAN32) expression in T cell-mediated immune responses and in multiple sclerosis 57
Overexpression of macrophage migration inhibitory factor and functionally‑related genes, D‑DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma 57
Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL 56
Th17 common genes in CD4 T-cells of HIV-1-infected naïve patients and elite controllers 56
Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents 56
In silico and in vivo analysis of IL37 in multiple sclerosis reveals its probable homeostatic role on the clinical activity, disability, and treatment with fingolimod 56
Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents 55
Effects of combined admistration of imatinib and sorafenib in a murine model of liver fibrosis 55
New melanoma therapeutics to improve adoptive T cell therapy - potential synergism of combinations 54
Evaluation of Toll-like Receptor 4 (TLR4) Involvement in Human Atrial Fibrillation: A Computational Study 53
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy 53
Therapeutic potential of carbon monoxide in multiple sclerosis 53
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer 53
The role of macrophage migration inhibitory factor in Alzheimer′s disease: Conventionally pathogenetic or unconventionally protective? 53
Retrospective follow-up analysis of the transcriptomic patterns of cytokines, cytokine receptors and chemokines at preconception and during pregnancy, in women with post-partum depression 53
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health 52
Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir. 51
In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells 50
HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives? 50
Transcriptomic analysis reveals involvement of the macrophage migration inhibitory factor gene network in duchenne muscular dystrophy 50
Gene Co-Expression Network Modular Analysis Reveals Altered Immune Mechanisms in HIV-HAND 49
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 49
CAN THE IMMUNOMODULATORY POTENTIAL OF CARBON-OXIDERELEASING MOLECULES BE TRANSLATED INTO THE CLINICAL SETTING AS A NOVEL THERAPEUTIC OPTION FOR THE TREATMENT OF AUTOIMMUNE DISEASES? 48
Targeting signaling pathways in prostate cancer 47
Totale 6.875
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.001
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021681 18 48 60 19 164 16 66 5 84 5 145 51
2021/2022873 77 120 4 19 145 22 127 33 66 3 20 237
2022/20231.593 125 82 29 127 145 247 18 349 352 27 48 44
2023/2024797 48 105 46 60 37 243 8 44 4 23 92 87
2024/20253.322 40 507 202 151 781 329 152 111 247 286 299 217
2025/2026195 195 0 0 0 0 0 0 0 0 0 0 0
Totale 8.499